期刊文献+

血浆miR-122在抗-HCV阳性献血者中表达的动态分析 被引量:5

Dynamic monitoring of expression of miR-122 in anti-HCV positive blood donors
下载PDF
导出
摘要 目的动态分析抗-HCV阳性献血者血浆miR-122的表达特点及与HCV感染诊断指标的关联。方法对133名抗-HCV阳性献血者、24名健康献血者及15名确证抗-HCV阳性追踪献血者血液标本抽提血浆miRNA,以实时荧光定量PCR法检测血浆miR-122,分析血浆miR-122相对表达量与HCV RNA、抗-HCV临界值指数(COI)等指标关联性。结果 ROC曲线分析:miR-122在抗-HCV+/HCV RNA+组和抗-HCV+/HCV RNA-组中诊断丙型肝炎的AUC(ROC曲线下面积)为0.830(95%CI:0.755-0.889),区分抗-HCV+/HCV RNA+组和抗-HCV+/HCV RNA-组的敏感性和特异性分别为74.7%和82.4%。追踪15例抗-HCV+/HCV RNA+献血者血浆miR-122表达明显降低(P<0.05)。结论血浆miR-122与HCV感染密切相关,确证HCV RNA感染献血者血浆miR-122随时间迁移表达降低。 Objective To dynamically monitor the expression of plasma miR- 122 in anti-HCV positive blood donors and analyze the relationship between miR-122 levels and HCV diagnostic test results. Methods 133 anti-HCV reactive donors, 24 healthy blood donors, 15 anti-HCV reactive and HCV RNA positive followed up blood donors were included in the study. The level of miR-122 in plasma were measured using real-time quantitative RT-PCR, and the relationship between miR-122 levels and HCV RNA, COI were statistically analyzed. Results From discriminating anti-HCV+/HCV RNA+ positive blood donors from those anti-HCV +/HCV RNA- negative people, the AUC-ROC ( the area under the ROC curve) was 0. 830 (95%CI :0. 755-0. 889) , and the sensitivity and specificity were 74. 7% and 82.4%, respectively. The expression of miR- 122 in plasma was significantly decreased in 15 anti-HCV+/HCV RNA+ patients (P〈 0. 05 ). Conclusion MiR-122 is closely related to HCV infection, and decreased with time in blood donors of HCV RNA infection.
作者 王立林 杨宝成 朱为刚 卢亮 洪文旭 孙元璋 龙洁萍 曾劲峰 李雪梅 WANG Lilin YANG Baocheng ZHU Weigang LU Liang HONG Wenxu SUN Yuanzhang LONG Jieping ZENG Jinffeng LI Xuemei.(Shenzhen blood center, Shenzhen 518035, China)
机构地区 深圳市血液中心
出处 《中国输血杂志》 北大核心 2017年第5期454-458,共5页 Chinese Journal of Blood Transfusion
基金 深圳市科技创新委员会项目(JCYJ20140403093211510) 深圳市科卫生计生系统科研项目(201401074 201401077)
关键词 丙型肝炎病毒 抗-HCV 血浆miR-122 HCV RNA 临界值指数 生物标志物 Hepatitis C virus Plasma miR-122 HCV RNA COI biomarker
  • 相关文献

参考文献1

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献981

同被引文献48

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部